Medications
Low-cost drug Heparin effective and safe treatment for COVID-19
Heparin, a widely available and affordable drug, has found to limit lung damage when inhaled by COVID-19 patients.
Jan 21, 2022
0
29
News tagged with lung damage
Medical research
'Decoy' protein works against multiple SARS-CoV-2 variants
A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers ...
Jan 19, 2022
0
291
Diseases, Conditions, Syndromes
Breathlessness in patients with long COVID may signal heart problems
A small study has suggested that COVID-19 patients who continue to be short of breath during physical activity one year after recovering from the infection may have suffered heart damage. The research is presented today at ...
Dec 9, 2021
0
107
Diseases, Conditions, Syndromes
Mitigating lung damage, mortality due to SARS-CoV-2
In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, ...
Oct 5, 2021
0
20
Diseases, Conditions, Syndromes
Why do short-lived lung infections lead to long-lasting lung damage?
The deadliest time in a viral respiratory illness sometimes is actually after the virus is cleared from the body. Destructive processes that are set in motion during an infection crest in the weeks after the virus is defeated, ...
Aug 24, 2021
0
102
Diseases, Conditions, Syndromes
New study finds fully recovered COVID-19 patients do not suffer permanent lung damage
A new study suggests that patients who contract COVID-19 and completely recover from all symptoms do not show evidence of lasting damage to the lungs.
Aug 13, 2021
0
78
Medications
Drug could potentially prevent respiratory and cardiovascular damage in COVID-19 patients
Scientists have identified a drug that can prevent the virus that causes COVID-19 from binding to human cells, potentially preventing damage to the lung, clot formation and the development of sepsis.
Jul 13, 2021
0
6
Diseases, Conditions, Syndromes
What drives severe lung inflammation in COVID-19?
A main feature of COVID-19 is lung inflammation and respiratory failure caused by an overexuberant immune response known as the cytokine storm. But why does the body produce such an excess of cytokine immune cells? New research ...
Jun 22, 2021
0
18
Medications
Common antibiotic found useful in accelerating recovery in tuberculosis patients
Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen ...
Jun 21, 2021
0
7
Diseases, Conditions, Syndromes
Researchers reveal SARS-CoV-2 distribution and relation to tissue damage in patients
Researchers have mapped the distribution of SARS-CoV-2, the virus that causes COVID-19, in deceased patients with the disease, and shed new light on how viral load relates to tissue damage.
Mar 30, 2021
0
6
